All News

Anika Reports Second Quarter 2018 Financial Results

July 25, 2018 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, today reported financial results for the second quarter ended June 30, 2018, along with business progress in the period. “Anika’s strategic initiatives in the second quarter were focused […]

JOURNEY™ II BCS Knee System demonstrates improved patient outcomes and lower healthcare costs

LONDON, July 25, 2018 /PRNewswire/ — Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announced positive clinical results concerning its JOURNEY™ II Bi-Cruciate Stabilized (BCS) knees. These results suggest JOURNEY II BCS is associated with significant healthcare economic benefits in patients implanted with this device compared to other knee systems. In a retrospective […]

FBC Device ApS Receives First FDA Clearance For Spinal Interbody Implant Providing Lordosis Adjustment from 9 to 21 Degrees to Aid Surgeons & Patients

July 24, 2018 AARHUS, Denmark–(BUSINESS WIRE)–FBC Device ApS, a medical device company focused on restoring natural alignment of the spine through innovative interbody implants, has received its first US FDA clearance for its technology, enabling access to the US market. Professor Finn Christensen, MD, PhD and founder and CEO of FBC Device says: “There is […]

Bone Biologics Completes $5.9 Million of Financing

July 23, 2018 BURLINGTON, Mass.–(BUSINESS WIRE)–Bone Biologics (OTCQB: BBLG), a developer of orthobiologic products for domestic and international spine fusion markets, announced today the completion of $5.9 million funding; $3.9 million in equity and a $2 million credit facility. Proceeds will be used for working capital, protein development, animal testing, regulatory and clinical expenses, as well […]

Histogenics Chief Operating Officer, Stephen Kennedy Appointed to Advanced Regenerative Manufacturing Institute’s Technology Advisory Sub-Committee

WALTHAM, Mass., July 23, 2018 (GLOBE NEWSWIRE) — Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored function, announced that Stephen Kennedy, Executive Vice President & Chief Operating Officer, has been appointed to the BioFabUSA Leadership Advisory Council and Technology Advisory Subcommittee (TASC) of […]

Bioventus Enters Into Definitive Agreement to Divest BMP Development Program to Viscogliosi Brothers, LLC

July 23, 2018 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, has entered into a definitive agreement to divest its next generation bone morphogenetic protein (BMP) development program to a new company formed by Viscogliosi Brothers, LLC (VB), a private equity investment firm focused on developing innovative neuromusculoskeletal technologies. Bioventus acquired the exclusive, worldwide license to […]

Using Patient-Specific 3D Printed Surgical Guides for Total Knee Replacement

by Hannah Rose Mendoza | Jul 13, 2018 | 3D Printing, Medical 3D Printing While surgery has always, ultimately, been about the patient, it hasn’t always been patient-centered. Historically, patients have not had an easy time of understanding exactly what their surgery entails and have often been treated as if they were ancillary to the surgical problem presented. This can’t all […]

OrthoSpin Ltd. Completes $3 Million Raise for Orthopedic Robotic External Fixation System

MISGAV, Israel, July 23, 2018 /PRNewswire/ — OrthoSpin Ltd. (“OrthoSpin”), a portfolio company of The Trendlines Group Ltd. (“Trendlines”) (SGX: 42T) (OTCQX: TRNLY), announced that it completed an investment round of $3 million for its smart, robotic external fixation system for orthopedic treatments. Johnson & Johnson Innovation – JJDC, Inc. (“JJDC”) led the investment round. External fixation devices are a common treatment […]

Titan Spine Appoints Peter Wehrly to Board of Directors

July 23, 2018 MEQUON, Wis.–(BUSINESS WIRE)–Titan Spine, Inc., a medical device surface technology company focused on developing innovative spinal interbody fusion implants, today announced the appointment of Peter Wehrly to its Board of Directors. Mr. Wehrly’s appointment, effective July 9, 2018, provides the Company with extensive medtech market knowledge and experience as it continues to […]

cultivate(MD) Funds Announce Investments Into Happe Spine

HOLLAND, Mich., July 19, 2018 /PRNewswire/ — Genesis Innovation Group, LLC, announces the formation of HAPPE Spine LLC as well as investments by cultivate(MD) Capital Fund I, LLC and cultivate(MD) Capital Fund II, LP into HAPPE Spine. Based on the work of Ryan K. Roeder, Ph.D. and researchers from the University of Notre Dame, HAPPE Spine has developed and will commercialize a […]

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1